These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 24288960)

  • 1. [WCN2013 satellite symposium "kidney and lipids" Report of the WCN2013 satellite symposium"kidney and lipids"].
    Saito T
    Nihon Jinzo Gakkai Shi; 2013; 55(7):1257-62. PubMed ID: 24288960
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of treatment for dyslipidemia in CKD].
    Ikemori A; Kimura K
    Nihon Jinzo Gakkai Shi; 2013; 55(7):1287-94. PubMed ID: 24288965
    [No Abstract]   [Full Text] [Related]  

  • 3. Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease.
    Calabresi L; Simonelli S; Conca P; Busnach G; Cabibbe M; Gesualdo L; Gigante M; Penco S; Veglia F; Franceschini G
    J Intern Med; 2015 May; 277(5):552-61. PubMed ID: 25039266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diabetic dyslipidaemia and the atherosclerosis].
    Márk L; Dani G
    Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease.
    Khurana M; Silverstein DM
    Pediatr Nephrol; 2015 Dec; 30(12):2073-84. PubMed ID: 25801207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormalities in plasma lipoprotein in familial partial lecithin:cholesterol acyltransferase deficiency.
    Kodama T; Akanuma Y; Okazaki M; Aburatani H; Itakura H; Takahashi K; Sakuma M; Takaku F; Hara I
    Biochim Biophys Acta; 1983 Aug; 752(3):407-15. PubMed ID: 6871236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyslipidemia in chronic kidney disease.
    Kowalski A; Krikorian A; Lerma EV
    Dis Mon; 2015 Sep; 61(9):396-402. PubMed ID: 26315102
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipids and diabetic nephropathy.
    Rosario RF; Prabhakar S
    Curr Diab Rep; 2006 Dec; 6(6):455-62. PubMed ID: 17118229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences.
    Vaziri ND
    Am J Physiol Renal Physiol; 2006 Feb; 290(2):F262-72. PubMed ID: 16403839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein L1: from obscurity to consistency to controversy.
    Lipkowitz MS
    Kidney Int; 2015 Jan; 87(1):14-7. PubMed ID: 25549121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of statins on renal function].
    Kasahara M
    Nihon Jinzo Gakkai Shi; 2013; 55(7):1295-300. PubMed ID: 24288966
    [No Abstract]   [Full Text] [Related]  

  • 13. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
    Rader DJ; Ikewaki K; Duverger N; Schmidt H; Pritchard H; Frohlich J; Clerc M; Dumon MF; Fairwell T; Zech L
    J Clin Invest; 1994 Jan; 93(1):321-30. PubMed ID: 8282802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: effects of incubation with lecithin: cholesterol acyltransferase in vitro.
    Norum KR; Glomset JA; Nichols AV; Forte T; Albers JJ; King WC; Mitchell CD; Applegate KR; Gong EL; Cabana V
    Scand J Clin Lab Invest Suppl; 1975; 142():31-55. PubMed ID: 169567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Familial alpha lipoprotein deficiency. Tangier disease, familial hypoalphalipoproteinemia and familial deficiency of lecithin cholesterol acyltransferase deficiency].
    Dioguardi N; Vergani C
    Minerva Med; 1983 Mar; 74(12):585-94. PubMed ID: 6835549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
    Stanely Mainzen Prince P; Kannan NK
    J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyslipidemia in renal disease: causes, consequences and treatment.
    Mesquita J; Varela A; Medina JL
    Endocrinol Nutr; 2010 Nov; 57(9):440-8. PubMed ID: 20850395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins in patients with chronic kidney disease: new evidence.
    Savino M; Garofalo C; De Paris V; Michini C; Pirro L; Palmisano R; Provenzano M; Minutolo R; Conte G; De Nicola L
    Minerva Urol Nefrol; 2013 Sep; 65(3):217-23. PubMed ID: 23872633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular diagnosis of lecithin: cholesterol acyltransferase deficiency in a presymptomatic proband.
    Cirera S; Julve J; Ferrer I; Mainou C; Bonet R; Martin-Campos JM; González-Sastre F; Blanco-Vaca F
    Clin Chem Lab Med; 1998 Jun; 36(7):443-8. PubMed ID: 9746267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid changes and statins in chronic renal insufficiency.
    Ritz E; Wanner C
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S226-30. PubMed ID: 17130266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.